IRIDEX CORP Deferred Revenue, Revenue Recognized
IRIDEX CORP (IRIX) reported Deferred Revenue, Revenue Recognized of $1.35 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2018-08-08
- IRIDEX CORP deferred revenue, revenue recognized for the quarter ending 2018-03-31 was $647.00K, a 114.24% increase year-over-year.
- IRIDEX CORP deferred revenue, revenue recognized for the quarter ending 2017-04-01 was $302.00K, a 10.12% decline year-over-year.
- IRIDEX CORP deferred revenue, revenue recognized for the quarter ending 2016-04-02 was $336.00K.
- IRIDEX CORP deferred revenue, revenue recognized for fiscal 2017 was $1.31M, a 3.24% decline from fiscal 2016.
- IRIDEX CORP deferred revenue, revenue recognized for fiscal 2016 was $1.36M.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2018-06-30 | $1.35M 10-Q · filed 2018-08-08 | |||
| 2018-03-31 | $647.00K 10-Q · filed 2018-05-08 | |||
| 2017-12-30 | $1.31M 10-K · filed 2018-03-14 | |||
| 2017-09-30 | $961.00K 10-Q · filed 2017-11-07 | |||
| 2017-07-01 | $628.00K 10-Q · filed 2018-08-08 | |||
| 2017-04-01 | $302.00K 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $1.36M 10-K · filed 2018-03-14 | |||
| 2016-10-01 | $1.03M 10-Q · filed 2017-11-07 | |||
| 2016-07-02 | $680.00K 10-Q · filed 2017-08-08 | |||
| 2016-04-02 | $336.00K 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |